Singapore, July 9 -- India's Godavari Biorefineries has been granted a patent by the Japan Patent Office for its breakthrough invention, "5-Hydroxy-1,4-Naphthalenedione for use in the treatment of cancer."

This patent covers a novel class of compounds that have demonstrated strong inhibitory effects on both standard cancer cells and resilient cancer stem cells. These compounds have demonstrated significant efficacy against multiple aggressive malignancies, including breast and prostate cancer.

Godavari Biorefineries is developing novel cancer therapies and now holds patent recognition across China, Spain, the United Kingdom, and multiple EU member states. Japan represents the world's third-largest pharmaceutical market, known for its ri...